SINE OFF

Product NDC
51645-269
11-digit product format
516450269
Labeler code
51645
Product ID
51645-269_994f716f-25e8-7007-e053-2995a90a308e
Type
HUMAN OTC DRUG
Nonproprietary name
ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Gemini Pharmaceuticals, Inc.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2010-07-05
Marketing end
2019-12-31
Substance
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
500 mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct51645-269DDiscontinued by firm2026-10-05
excluded packagepackage51645-26951645-269-12DDiscontinued by firm2026-10-05
excluded packagepackage51645-26951645-269-66DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage51645-269-12d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage51645-269-66d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage51645-269-12f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage51645-269-66f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage51645-269-122ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage51645-269-662ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage51645-269-12a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage51645-269-66a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage51645-269-12cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage51645-269-66cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage51645-269-12cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage51645-269-66cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage51645-269-12302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage51645-269-66302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage51645-269-12ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage51645-269-66ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage51645-269-120efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage51645-269-660efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage51645-269-12ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage51645-269-66ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage51645-269-12367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage51645-269-66367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage51645-269-12557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage51645-269-66557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61USINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48SINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOASINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8SINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
HYPROMELLOSEINACTIVE INGREDIENT3NXW29V3WOSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30SINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ESINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3SINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4SINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPSINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1
TRIACETININACTIVE INGREDIENTXHX3C3X673SINE OFF MAXIMUM STRENGTH (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [GEMINI PHARMACEUTICALS, INC.]1